The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes
Abstract
CONTEXT: Hepatokines have emerged as liver-derived hormone-like factors. Plasma fibroblast growth factor (FGF)-21 and follistatin increase with a high glucagon to insulin ratio and exercise, and resting levels are elevated in patients with type 2 diabetes (T2D). OBJECTIVE: The objective of the study was to investigate the regulatory roles of glucagon to insulin ratio and T2D on exercise-induced FGF21 and follistatin secretion. Design /Interventions: Young healthy males performed a 2-hour bicycle exercise bout followed by 5 hours of rest in supine position with and without a pancreatic clamp blocking the increase in the glucagon to insulin ratio. In addition, we evaluated exercise-induced plasma FGF21 and follistatin in patients with T2D compared with healthy controls in response to 1 hour of bicycle exercise followed by a 3-hour recovery period. RESULTS: In healthy individuals, we observed a 10-fold (P < .002) increase in the glucagon to insulin ratio during exercise, which was abolished by the pancreatic clamp. Exercise with the pancreatic clamp completely blunted the exercise-induced increase in FGF21 (P = .007), whereas the induction of follistatin was approximately 50% reduced (P = .04). Exercise-induced FGF21 secretion was completely absent in patients with T2D, whereas the exercise-induced follistatin increase was impaired. CONCLUSIONS/INTERPRETATION: Exercise-induced increases in plasma FGF21 and follistatin are attenuated by the pancreatic clamp, indicating important roles for glucagon and insulin as upstream regulators. For follistatin, an additional regulatory mechanism must exist. Our data further show that exercise-induced FGF21 and follistatin secretion are impaired in patients with T2D. The magnitude of changes in glucagon and insulin or the sensitivity to these hormones seems central in the regulation of FGF21 and follistatin in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, patients with obesity-related insulin resistance have an impaired FGF21 upregulation after exercise [156,157].”
In the citing paper
“Expectedly, like FGF21, patients with obesity-related insulin resistance present increased basal levels of follistatin [157,180], but its exercise-induced release by the liver is blunted [157].”
In the citing paper
“Clinical studies in patients with insulin resistant conditions have described dampened upregulation of exercise-induced factors, such as FGF21 and follistatin, most likely due to an altered glucagon-to-insulin ratio [156,157,280]”
In the citing paper
“Patients with type 2 diabetes have slightly elevated levels of circulating FST and plasma levels associated with glycemic parameters in these patients [188,191,192] (Table 1).”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [192]
Citations
Cites
2 retracted
Berglund, E. D., Kang, L., Lee, R. S., Hasenour, C. M., Lustig, D. G., Lynes, S. E., Donahue, E. P., Swift, L. L., Charron, M. J., & Wasserman, D. H. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00263.2010 · Cited by 100
RetractedHepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver
Berglund, E. D., Lustig, D. G., Baheza, R. A., Hasenour, C. M., Lee, R. S., Donahue, E. P., Lynes, S. E., Swift, L. L., Charron, M. J., Damon, B. M., et al. (2011) · Diabetes · doi:10.2337/db11-0455 · Cited by 44
RetractedInagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T., Schilske, H. K., & Moller, D. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.005 · Cited by 885
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Dushay, J., Chui, P. C., Gopalakrishnan, G. S., Varela–Rey, M., Crawley, M., Fisher, F. M., Badman, M. K., Martinez–Chantar, M. L., & Maratos–Flier, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.054 · Cited by 607
Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
Markan, K. R., Naber, M. C., Ameka, M. K., Anderegg, M. D., Mangelsdorf, D. J., Kliewer, S. A., Mohammadi, M., & Potthoff, M. J. (2014) · Diabetes · doi:10.2337/db14-0595 · Cited by 590
Gälman, C., Lundåsen, T., Kharitonenkov, A., Bina, H. A., Eriksson, M., Hafström, I., Dahlin, M., Åmark, P., Angelin, B., & Rudling, M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.014 · Cited by 512
The role of hepatokines in metabolism
Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500
Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis
Amthor, H., Nicholas, G., McKinnell, I., Kemp, C. F., Sharma, M., Kambadur, R., & Patel, K. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.01.046 · Cited by 401
Cited by
Sorted by citations
Muscle–Organ Crosstalk: The Emerging Roles of Myokines
Severinsen, M. C. K., & Pedersen, B. K. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa016 · Cited by 1,226
“The Fibroblast growth factor 21 (FGF-21) (150) and Follistatin (151) are released from human liver during exercise and this release is controlled by the glucagon-to-insulin ratio (152).”
BackgroundSelf-citationKalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Physical activity and muscle-brain crosstalk
Pedersen, B. K. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0174-x · Cited by 772
Self-citationThe Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
Gonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
Staiger, H., Keuper, M., Berti, L., Hrabě de Angelis, M., & Häring, H.-U. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00016 · Cited by 270
Exercise sustains the hallmarks of health
Qiu, Y., Fernández-García, B., Lehmann, H. I., Li, G., Kroemer, G., López-Otín, C., & Xiao, J. (2023) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2022.10.003 · Cited by 270
Hepatokines and metabolism: Deciphering communication from the liver
Jensen-Cody, S. O., & Potthoff, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101138 · Cited by 252
Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
de Oliveira dos Santos, A. R., de Oliveira Zanuso, B., Miola, V. F. B., Barbalho, S. M., Santos Bueno, P. C., Flato, U. A. P., Detregiachi, C. R. P., Buchaim, D. V., Buchaim, R. L., Tofano, R. J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052639 · Cited by 189
Metabolic communication during exercise
Murphy, R. M., Watt, M. J., & Febbraio, M. A. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0258-x · Cited by 162
Stress-induced FGF21 and GDF15 in obesity and obesity resistance
Keipert, S., & Ost, M. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.08.008 · Cited by 132
Ma, Y., Kuang, Y., Bo, W., Liang, Q., Zhu, W., Cai, M., & Tian, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212341 · Cited by 130
Molecular mechanisms underlying physical exercise-induced brain BDNF overproduction
Cefis, M., Chaney, R., Wirtz, J., Méloux, A., Quirié, A., Leger, C., Prigent‐Tessier, A., & Garnier, P. E. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1275924 · Cited by 145
Morville, T. H., Sahl, R. E., Trammell, S. A. J., Svenningsen, J. S., Gillum, M. P., Helge, J. W., & Clemmensen, C. (2018) · JCI Insight · doi:10.1172/jci.insight.122737 · Cited by 112
Human Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues
Singh, R., Barrios, A., Dirakvand, G., & Pervin, S. (2021) · Cells · doi:10.3390/cells10113030 · Cited by 114
Nay, K., Smiles, W. J., Kaiser, J., McAloon, L. M., Loh, K., Galić, S., Oakhill, J. S., Gundlach, A. L., & Scott, J. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084052 · Cited by 112
Inactivating hepatic follistatin alleviates hyperglycemia
Tao, R., Wang, C., Stöhr, O., Qiu, W., Hu, Y., Miao, J., Dong, X. C., Leng, S., Stefater, M., Stylopoulos, N., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0048-0 · Cited by 104
AMPK and the Endocrine Control of Metabolism
Townsend, L. K., & Steinberg, G. R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad012 · Cited by 114
Fibroblast Growth Factor 21 and the Adaptive Response to Nutritional Challenges
Martínez‐Garza, Ú., Torres‐Oteros, D., Yarritu, A., Marrero, P. F., Haro, D., & Relat, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194692 · Cited by 88
Circulating FGF21 Levels in Human Health and Metabolic Disease
Keuper, M., Häring, H., & Staiger, H. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0879-2968 · Cited by 83
Effect of Various Exercise Regimens on Selected Exercise-Induced Cytokines in Healthy People
Domin, R., Dadej, D., Pytka, M., Zybek-Kocik, A., Ruchała, M., & Guzik, P. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031261 · Cited by 79
“Fibroblast growth factor 21 (FGF21) and FST are produced mainly by the liver and both are considered hepatokines, nonetheless, their concentration alters in response to exercise classifying them as exercise-induced cytokines [35].”
BackgroundJaberi, S., & Fahnestock, M. L. (2023) · Biomolecules · doi:10.3390/biom13111577 · Cited by 78
Kruse, R., Vienberg, S. G., Vind, B. F., Andersen, B., & Højlund, K. (2017) · Diabetologia · doi:10.1007/s00125-017-4373-5 · Cited by 69
Factors mediating exercise‐induced organ crosstalk
Sabaratnam, R., Wojtaszewski, J. F. P., & Højlund, K. (2022) · Acta Physiologica · doi:10.1111/apha.13766 · Cited by 70
Boa, B. C. S., Yudkin, J. S., van Hinsbergh, V. W. M., Bouskela, E., & Eringa, E. C. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13732 · Cited by 65
Shabkhiz, F., Khalafi, M., Rosenkranz, S., Karimi, P., & Moghadami, K. (2021) · European Journal of Sport Science · doi:10.1080/17461391.2020.1762755 · Cited by 64
Circulating follistatin in relation to energy metabolism
Hansen, J. S., & Plomgaard, P. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.06.002 · Cited by 62
Self-citationIngerslev, B., Hansen, J. S., Hoffmann, C., Clemmesen, J. O., Secher, N. H., Scheler, M., Hrabĕ de Angelis, M., Häring, H. U., Pedersen, B. K., Weigert, C., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.018 · Cited by 61
“fasting: H-4-2011-055; hormone infusion trial, and exercise trial with liver vein catheterization [24] and exercise with the pancreatic clamp [27]) in accordance with the Helsinki Declaration.”
BackgroundMethodSelf-citationHepatokines—A novel group of exercise factors
Weigert, C., Hoene, M., & Plomgaard, P. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2216-y · Cited by 57
Self-citationSargeant, J. A., Aithal, G. P., Takamura, T., Misu, H., Takayama, H., Douglas, J. A., Turner, M. C., Stensel, D. J., Nimmo, M. A., Webb, D. R., et al. (2018) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2017-0639 · Cited by 56
Follistatins in glucose regulation in healthy and obese individuals
Perakakis, N., Kokkinos, A. D., Peradze, N., Tentolouris, N., Ghaly, W., Tsilingiris, D., Alexandrou, A. P., & Mantzoros, C. S. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13572 · Cited by 56
Skeletal Muscle and Bone – Emerging Targets of Fibroblast Growth Factor-21
Sun, H., Sherrier, M. C., & Li, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.625287 · Cited by 54
Dantas, W. S., Roschel, H., Murai, I. H., Gil, S., Davuluri, G., Axelrod, C. L., Ghosh, S., Newman, S. S., Zhang, H., Shinjo, S. K., et al. (2020) · Diabetes · doi:10.2337/db19-1180 · Cited by 54
Role of exercise-induced hepatokines in metabolic disorders
Ennequin, G., Sirvent, P., & Whitham, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2018 · Cited by 54
Perakakis, N., Mougios, V., Fatouros, I., Siopi, A., Draganidis, D., Peradze, N., Ghaly, W., & Mantzoros, C. S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01056 · Cited by 52
Sabaratnam, R., Pedersen, A. J. T., Kristensen, J. M., Handberg, A., Wojtaszewski, J. F. P., & Højlund, K. (2018) · Physiological Reports · doi:10.14814/phy2.13723 · Cited by 50
Effect of exercise intensity on circulating hepatokine concentrations in healthy men
Willis, S. A., Sargeant, J. A., Thackray, A. E., Yates, T. E., Stensel, D. J., Aithal, G. P., & King, J. A. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0818 · Cited by 48
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
Kim, T. H., Hong, D.-G., & Yang, Y. M. (2021) · Biomedicines · doi:10.3390/biomedicines9121903 · Cited by 57
Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
Carneros, D., López‐Lluch, G., & Bustos, M. (2020) · Nutrients · doi:10.3390/nu12113472 · Cited by 48
Loyd, C., Magrisso, I. J., Haas, M., Balusu, S., Krishna, R., Itoh, N., Sandoval, D. A., Pérez–Tilve, D., Obici, S., & Habegger, K. M. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00456.2016 · Cited by 49
Looking on the “brite” side exercise-induced browning of white adipose tissue
Townsend, L. K., & Wright, D. C. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2177-1 · Cited by 44
Khalafi, M., Aria, B., Symonds, M. E., & Rosenkranz, S. K. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114272 · Cited by 52
Exercise ameliorates the FGF21–adiponectin axis impairment in diet-induced obese mice
Yang, W., Liu, L., Wei, Y., Fang, C., Zhou, F., Chen, J., Han, Q., Huang, M., Tan, X., Liu, Q., et al. (2019) · Endocrine Connections · doi:10.1530/ec-19-0034 · Cited by 39
GDF15 is an exercise-induced hepatokine regulated by glucagon and insulin in humans
Plomgaard, P., Hansen, J. S., Townsend, L. K., Gudiksen, A., Secher, N. H., Clemmesen, J. O., Støving, R. K., Goetze, J. P., Wright, D. C., & Pilegaard, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1037948 · Cited by 43
Self-citationHepatokines as a Molecular Transducer of Exercise
Seo, D. Y., Park, S.-H., Marquez, J. C., Kwak, H., Kim, T. N., Bae, J. H., Koh, J., & Han, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030385 · Cited by 37
New Horizon: Exercise and a Focus on Tissue-Brain Crosstalk
Townsend, L. K., MacPherson, R. E. K., & Wright, D. C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab333 · Cited by 36
Khalafi, M., Alamdari, K. A., Symonds, M. E., Nobari, H., & Carlos-Vivas, J. (2021) · HORMONES · doi:10.1007/s42000-020-00245-3 · Cited by 34
Circulating Follistatin and Activin A and Their Regulation by Insulin in Obesity and Type 2 Diabetes
Sylow, L., Vind, B. F., Kruse, R., Møller, P. M., Wojtaszewski, J. F. P., Richter, E. A., & Højlund, K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa090 · Cited by 35
Beige Fat, Adaptive Thermogenesis, and Its Regulation by Exercise and Thyroid Hormone
Phillips, K. J. (2019) · Biology · doi:10.3390/biology8030057 · Cited by 35
Du, Y., Xu, C., Shi, H., Jiang, X., Tang, W., Wu, X., Chen, M., Li, H., Zhang, X., & Cheng, Q. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02481-7 · Cited by 32
Anti-inflammatory effects of exercise training in adipose tissue do not require FGF21
Porter, J. W., Rowles, J. L., Fletcher, J. A., Zidon, T. M., Winn, N. C., McCabe, L., Park, Y.-M., Perfield, J. W., Thyfault, J. P., Rector, R. S., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0190 · Cited by 31
Altered GDF15 and FGF21 Levels in Response to Strenuous Exercise: A Study in Marathon Runners
Campderrós, L., Sánchez‐Infantes, D., Villarroya, J., Nescolarde, L., Bayés‐Genís, A., Cereijo, R., Roca, E., & Villarroya, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.550102 · Cited by 34
Yang, B., Lu, L., Zhou, D., Fan, W., Barbier‐Torres, L., Steggerda, J. A., Yang, H., & Yang, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1007944 · Cited by 30
Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice
Luo, H.-Y., Mu, W.-J., Chen, M., Zhu, J., Li, Y., Li, S., Yan, L.-J., Li, R.-Y., Yin, M.-T., Li, X., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155916 · Cited by 28
Crosstalk Communications Between Islets Cells and Insulin Target Tissue: The Hidden Face of Iceberg
Langlois, A., Dumond, A., Vion, J., Pinget, M., & Bouzakri, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.836344 · Cited by 32
Moderate-Intensity Continuous Training Improves FGF21 and KLB Expression in Obese Mice
Xiong, Y., Chen, Y., Liu, Y., & Zhang, B. (2020) · Biochemistry (Moscow) · doi:10.1134/s000629792008009x · Cited by 26
Relationship between FGF21 and drug or nondrug therapy of type 2 diabetes mellitus
Guo, C. Y., Zhao, L., Li, Y., Deng, X., & Yuan, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29879 · Cited by 21
Physical Activity, Obesity and Weight Loss Maintenance
Brandt, C., & Pedersen, B. K. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_575 · Cited by 21
Self-citationSabaratnam, R., Kristensen, J. M., Pedersen, A. J. T., Kruse, R., Handberg, A., Wojtaszewski, J. F. P., & Højlund, K. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae032 · Cited by 19
Endocrine Mechanisms Connecting Exercise to Brown Adipose Tissue Metabolism: a Human Perspective
Méndez-Gutiérrez, A., Osuna‐Prieto, F. J., Aguilera, C. M., Ruiz, J. R., & Sánchez‐Delgado, G. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01319-7 · Cited by 17
Vasyukova, O. V., Kasyanova, Y. V., Okorokov, P. L., & Bezlepkina, O. B. (2021) · Problems of Endocrinology · doi:10.14341/probl12779 · Cited by 18
Diabetes Mellitus Should Be Considered While Analysing Sarcopenia-Related Biomarkers
Rentflejsz, J., & Wojszel, Z. B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13041107 · Cited by 18
Lombardi, G., Sansoni, V., & Banfi, G. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.07.11 · Cited by 17
Tao, R., Stöhr, O., Wang, C., Qiu, W., Copps, K. D., & White, M. F. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101703 · Cited by 14
Periodized low protein-high carbohydrate diet confers potent, but transient, metabolic improvements
Li, Z., Rasmussen, M. L., Li, J., Henríquez‐Olguín, C., Knudsen, J. R., Madsen, A. B., Sanchez-Quant, E., Kleinert, M., & Jensen, T. E. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.08.008 · Cited by 15
Lim, J. Y., & Kim, E. (2023) · Metabolites · doi:10.3390/metabo13090979 · Cited by 13
Exercise and inactivity as modifiers of β cell function and type 2 diabetes risk
Hall, L. G., Thyfault, J. P., & Johnson, J. D. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00472.2022 · Cited by 15
Do diabetes and obesity affect the metabolic response to exercise?
Plomgaard, P., & Weigert, C. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000379 · Cited by 10
Self-citationThe Effect of Exercise on Spexin and Follistatin in Elderly Individuals
Ayaz, E. Y., Dinçer, B., Cinbaz, G., Karacan, E., Benli, R. K., Mete, E., Bilgiç, H., & Mesçi, B. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13692 · Cited by 9
Tsuchiya, Y., & Goto, K. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155553 · Cited by 9
Liu, X., Zhang, N., Sung, B., & Wang, B. (2022) · Physiological Research · doi:10.33549/physiolres.934833 · Cited by 8
The Regulation of Circulating Hepatokines by Fructose Ingestion in Humans
Richter, M. M., & Plomgaard, P. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab121 · Cited by 7
Self-citationKabadi, U. M. (2021) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2021.113007 · Cited by 7
In Vivo Detection of Human Brown Adipose Tissue During Cold and Exercise by PET/CT
Nascimento, E. B. M., & Lichtenbelt, W. D. V. M. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_121 · Cited by 7
Roles of FGF21 and irisin in obesity-related diabetes and pancreatic diseases
Xie, T., & Leung, P. S. (2020) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000039 · Cited by 7
Skeletal Muscle as Endocrine Organ
Ma, M., Zhang, Z., Hai, B., & Zhang, Y. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-88361-3_22 · Cited by 9
Russell‐Guzmán, J., Karachon, L., Gacitúa, T. A., Freundlich, A., Poblete-Aro, C., & Rodrigo, R. (2018) · Sport Sciences for Health · doi:10.1007/s11332-018-0459-9 · Cited by 7
Vizvari, E., Farzanegi, P., & Sourati, H. A. (2020) · Medical Laboratory Journal · doi:10.52547/mlj.14.6.17 · Cited by 4
Zahedani, S. S., & sayadzai, N. (2018) · Medical Laboratory Journal · doi:10.29252/mlj.12.2.7 · Cited by 4
Pervin, S., Wilson, N. Y. A. H., Reddy, S. T., & Singh, R. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88294 · Cited by 3
Roohbakhsh, E., Barari, A., & Abbaszadeh, H. (2021) · Quarterly of Horizon of Medical Sciences · doi:10.32598/hms.27.2.3456.1 · Cited by 4
Exercise Suppresses Appetite in Obesity: A Biochemical, Metabolic, and Molecular Approach
Razi, O., Zamani, N., de Moraes, C., Laher, I., & Hadjicharalambous, M. (2025) · Applied Sciences · doi:10.3390/app15116191 · Cited by 4
Huang, S., Chen, Z., Li, H.-M., Zheng, L., Zhou, Z., Peng, X., & Tang, C. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1642389 · Cited by 2
Liver–pancreas communication in disease and drug development
Jia, Y., Zhu, Q., Pan, Q., Lu, G., & Xiao, J. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.018 · Cited by 2
azhir, S., Alijani, E., Martínez-Huenchullán, S., Amni, H., Baker, J., & Farhani, F. (2022) · Retos · doi:10.47197/retos.v44i0.91770 · Cited by 2
Ghiyami, S. H., Afroundeh, R., Pourvaghar, M. J., Sadeghi, A., & Katebi, L. (2023) · Complementary Medicine Journal · doi:10.61186/cmja.12.4.1 · Cited by 2
Salisbury, D. L., Li, D., Todd, M. W., Ng, T. K. S., & Yu, F. (2023) · Journal of Vascular Diseases · doi:10.3390/jvd2030027 · Cited by 2
Fibroblast growth factor 21: new insights from human studies
Hansen, J. S., & Plomgaard, P. (2016) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000084 · Cited by 2
Self-citationDurrer, C. G., Islam, H., Cen, H. H., Moya-Garzón, M. D., Lyu, X., McKelvey, S., Singer, J., Batterham, A. M., Long, J. Z., Johnson, J. D., et al. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00807-x · Cited by 2
Metformin increases glycolysis and the stress-induced cytokine GDF15 but not FGF21 in humans
Kolnes, K. J., Møller, P. M., Kruse, R., Christensen, M. H., Kjøbsted, R., Hey-Mogensen, M., Andersen, B., Handberg, A., & Højlund, K. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1797525 · Cited by 2
Folistatina, resistencia a la insulina y composición corporal en adultos colombianos
Toloza, F. J. K., Ricardo-Silgado, M. L., Mantilla-Rivas, J. O., Morales-Álvarez, M. C., Pérez-Matos, M. C., Pinzón-Cortés, J. A., Pérez-Mayorga, M., & Mendivil, C. O. (2018) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.5.1.336 · Cited by 1
Švecová, M., Bakalář, B., Vyklicka, K., Tomandlová, M., Böhm, J., Brenerová, P., Janošek, J., Lipový, B., Zajíček, R., & Linhartová, P. B. (2025) · Burns · doi:10.1016/j.burns.2025.107633 · Cited by 1
Botelho, W. G. N., César, A. R. D. A., & Teixeira, K. N. (2021) · Research Society and Development · doi:10.33448/rsd-v10i16.24223
Bock, P. M., Monteiro, R. B., Berlanda, G., Casali, K. R., & Schaan, B. D. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000482 · Cited by 1
Le, N. B. A., NGUYEN, H. N., & NGUYEN, T. M. N. (2023) · Tạp chí Dinh dưỡng và Thực phẩm · doi:10.56283/1859-0381/420
(2023) · Wiley eBooks · doi:10.1002/9781394236329.refs
Cross-talk between hepatokines as Liver indused-exercise factors and organokinesPreprint
Rad, R. S. (2023) · Research Square · doi:10.21203/rs.3.rs-3734627/v1
Role of Myokines and prospects for their role in Diabetes Mellitus Therapy
Nuriya, K., Farida, M., Sharma, R., Liliya, S., Mkhitaryan, X. E., Chergizova, B., Salikhova, Y., Niyazova, Y., Ryspayeva, G., Evnevich, A., et al. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00786
Can we run away from the metabolic side effects of antipsychotics?
Akcan, M., & Wright, D. C. (2025) · Translational Exercise Biomedicine · doi:10.1515/teb-2025-0016
Metadata
- Authors
- Hansen, J. S., Pedersen, B. K., Xu, G., Lehmann, R., Weigert, C., & Plomgaard, P.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Plomgaard, Peter
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-07
- Volume
- 101
- Issue
- 7
- Pages
- 2816-2825
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2375156733
- Cited by
- 106
- References
- 35
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 6 · 2023: 13 · 2022: 9 · 2021: 17 · 2020: 15 · 2019: 9 · 2018: 12 · 2017: 8 · 2016: 4
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Dalian Institute of Chemical Physics, CAS Institutional Repository (submittedVersion)
- Site cant be reached (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
- Keywords
- FGF21, follistatin, hepatic hormones, physical activity, type 2 diabetes, glucagon, insulin, hormonal regulation
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Fibroblast Growth Factors, Glucagon, Humans, Insulin, Insulin Resistance, Male, Pancreas, Glucose Clamp Technique, Exercise, Cross-Over Studies, Follistatin, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review